Skip to main content
VulnerabilityPublished Updated

CVE-2026-60956: Oracle JD Edwards EnterpriseOne US Payroll · Improper Access Control

Affects Oracle JD Edwards EnterpriseOne US PayrollSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 7.5 High.

Data as of 16 Nov 2026, 20:25 UTC

CVSS 3.1 base score
7.5High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 27% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 18 Aug 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
Oracle CorporationJD Edwards EnterpriseOne US PayrollAffected
  • =9.2
Fixed in–

AI-suggested

Oracle has released security patches addressing this vulnerability as part of its August 2026 Critical Security Patch Update. Customers are strongly advised to apply the relevant patches promptly to mitigate this vulnerability. Oracle recommends remaining on actively-supported versions and applying security patches without delay. No additional mitigation steps are specified beyond patching.

Description

CVE-2026-60956 is a vulnerability in Oracle JD Edwards EnterpriseOne US Payroll version 9.2. It allows a low privileged attacker with network access via JDENET to compromise the US Payroll component. The vulnerability is difficult to exploit but can lead to full takeover of the affected product. It has a CVSS 3.1 base score of 7.5, indicating high severity with impacts on confidentiality, integrity, and availability.

References

Community reviews

Loading reviews…